Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Minimed Group Inc (MMED)

Minimed Group Inc (MMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System GlobeNewswire - Tue Apr 28, 8:05AM CDT

BRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE) -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new software for the MiniMed™...

MMED : 12.40 (+3.16%)
MiniMed to announce financial results for its fourth quarter and full fiscal year 2026 PR Newswire - Mon Apr 13, 3:01PM CDT

NORTHRIDGE, Calif. , April 13, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it will report financial results for its fourth quarter...

MMED : 12.40 (+3.16%)
MiniMed Announces FDA Clearance of MiniMed Flex™, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design PR Newswire - Wed Mar 18, 8:06AM CDT

MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery...

MMED : 12.40 (+3.16%)
MiniMed announces closing of Initial Public Offering PR Newswire - Mon Mar 9, 3:59PM CDT

NORTHRIDGE, Calif. , March 9, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) today announced the closing of its previously announced initial public offering (IPO) of 28,000,000...

MMED : 12.40 (+3.16%)
MiniMed to begin trading on Nasdaq Global Select Market PR Newswire - Fri Mar 6, 8:00AM CST

GALWAY, Ireland , March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on...

MMED : 12.40 (+3.16%)
MDT : 79.45 (+0.10%)
MiniMed announces launch of IPO roadshow PR Newswire - Tue Feb 24, 7:30AM CST

GALWAY, Ireland , Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial...

MMED : 12.40 (+3.16%)
MDT : 79.45 (+0.10%)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024 BayStreet.ca - Fri Feb 16, 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

NUMIF : 0.0359 (-20.22%)
CMPS : 8.55 (+2.00%)
ATAI : 4.21 (+2.10%)
NUMI.TO : 0.0500 (+42.86%)
MMED : 12.40 (+3.16%)
MNMD : 15.02 (+1.01%)
SEEL : 0.3900 (-27.79%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD BayStreet.ca - Wed Feb 14, 2024

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

NUMIF : 0.0359 (-20.22%)
CMPS : 8.55 (+2.00%)
ATAI : 4.21 (+2.10%)
NUMI.TO : 0.0500 (+42.86%)
NUMI : 25.13 (-0.14%)
MMED : 12.40 (+3.16%)
MNMD : 15.02 (+1.01%)
SEEL : 0.3900 (-27.79%)
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition FinancialNewsMedia - Wed Jan 24, 2024

EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END

CMPS : 8.55 (+2.00%)
CYBN.NE : 11.5800 (+4.23%)
ATAI : 4.21 (+2.10%)
MMED.NE : 14.9000 (+9.48%)
MMED : 12.40 (+3.16%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
SEEL : 0.3900 (-27.79%)
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031 FinancialNewsMedia - Wed Jul 26, 2023

EQNX::TICKER_START (NYSE:CYBN),NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(OTCQX:NUMIF) EQNX::TICKER_END

NUMIF : 0.0359 (-20.22%)
CMPS : 8.55 (+2.00%)
CYBN.NE : 11.5800 (+4.23%)
MMED.NE : 14.9000 (+9.48%)
NUMI.TO : 0.0500 (+42.86%)
MMED : 12.40 (+3.16%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
SEEL : 0.3900 (-27.79%)

Barchart Exclusives

Silver Prices Have Pulled Back, But Bank of America Predicts They Could Soar to $309 Before the End of 2026. How? Barchart - 19 minutes ago
Bank of America’s $309 silver call is really an upper‑bound scenario built on the gold‑to‑silver ratio snapping back to rare historical extremes, not a central forecast. Getting there would require tight supply, surging industrial and safe‑haven demand, and a dramatic ratio squeeze all at once. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.